TELA Bio TELA
NASDAQ TELA
$0.65 +0.01 (+1.09%)
At close: Aug 21, 2026 · 4:00 PM EDT

TELA Bio (TELA) Short-term Investments (2019 - 2020)

TELA Bio (TELA) posted quarterly Short-term Investments of $5.3 million for Q1 2020, down 43.04% quarter-over-quarter from $9.3 million in Q4 2019.

TELA Bio (TELA) Short-term Investments (2019 - 2020) Analysis & Trends

TELA Bio's Short-term Investments history runs 2 years deep, the most recent figure standing at $5.3 million for Q1 2020.

  • In Q1 2020, Short-term Investments changed N/A year-over-year to $5.3 million; the TTM figure through Mar 2020 stood at $5.3 million (changed N/A YoY), while the FY2019 annual figure was $9.3 million, changed N/A from the prior year.
  • Short-term Investments for Q1 2020 stood at $5.3 million, down from $9.3 million in the prior quarter.
  • The five-year high for Short-term Investments was $9.3 million in Q4 2019, with the low at $5.3 million in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 TELA Bio 35.91 Mn 5.49 Mn 13.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2020 5.29 Mn
Dec 31, 2019 9.29 Mn